These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37278432)

  • 1. Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo.
    Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Mumba Ngoyi D; Akilimali Zalagile P; de-la-Torre A
    BMJ Open Ophthalmol; 2023 Jan; 8(1):. PubMed ID: 37278432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Serological Characteristics of Ocular Toxoplasmosis in the Democratic Republic of Congo.
    Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Mumba Ngoyi D; Kilangalanga Ngoy J; Ngoyi Bambi MT; Kadima Mutombo T; Kintoki Makela G; Ngandowe Nzamokili L; de-la-Torre A
    Ocul Immunol Inflamm; 2023 Sep; 31(7):1522-1527. PubMed ID: 36328437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and clinical pattern of ocular toxoplasmosis in Kinshasa].
    Nsiangani Lusambo N; Kaimbo Wa Kaimbo D
    J Fr Ophtalmol; 2019 Oct; 42(8):900-906. PubMed ID: 31248609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients.
    Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Ngoyi Mumba DM; de-la-Torre A
    BMC Ophthalmol; 2023 Oct; 23(1):440. PubMed ID: 37907920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.
    Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O
    Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of ocular toxoplasmosis presenting at a tertiary eye care center in Korean patients.
    Kim M; Choi SY; Won JY; Park YH
    Medicine (Baltimore); 2018 Apr; 97(15):e0399. PubMed ID: 29642204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo.
    Doudou Y; Renaud P; Coralie L; Jacqueline F; Hypolite S; Hypolite M; Patrick M; Andreia Ida L; Van Sprundel M; Marleen B; Van Geertruyden JP; Pascal L
    Asian Pac J Trop Biomed; 2014 Jan; 4(1):69-74. PubMed ID: 24144134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ocular toxoplasmosis in Brazil.
    Ferreira AI; De Mattos CC; Frederico FB; Meira CS; Almeida GC; Nakashima F; Bernardo CR; Pereira-Chioccola VL; De Mattos LC
    Epidemiol Infect; 2014 Jan; 142(1):142-8. PubMed ID: 23507508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuban Ocular Toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba.
    Bustillo JL; Diaz JD; Pacheco IC; Gritz DC
    Br J Ophthalmol; 2015 Mar; 99(3):382-6. PubMed ID: 25253767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic uveitis in Kinshasa (D R Congo).
    Kaimbo Wa Kimbo D; Bifuko A; Dernouchamps JP; Missotten L
    Bull Soc Belge Ophtalmol; 1998; 270():95-100. PubMed ID: 9919786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and epidemiological aspects of toxoplasmosis in patients with vision problems].
    Samudio M; Acosta ME; Castillo V; Guillén Y; Licitra G; Aria L; Cibils P; Rojas A; Cibils D; Meza T; Infanzón B; Miño de Kaspar H
    Rev Chilena Infectol; 2015 Dec; 32(6):658-63. PubMed ID: 26928502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran.
    Hosseini SM; Moghaddas E; Sharifi K; Dadgar Moghaddam M; Shamsian SA
    Int Ophthalmol; 2018 Dec; 38(6):2527-2533. PubMed ID: 29335806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.
    Greigert V; Pfaff AW; Sauer A; Filisetti D; Candolfi E; Villard O
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31554726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis.
    Cifuentes-González C; Rojas-Carabali W; Pérez ÁO; Carvalho É; Valenzuela F; Miguel-Escuder L; Ormaechea MS; Heredia M; Baquero-Ospina P; Adan A; Curi A; Schlaen A; Urzua CA; Couto C; Arellanes L; de-la-Torre A
    PLoS One; 2023; 18(4):e0283845. PubMed ID: 37011101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo.
    Kilangalanga NJ; Nsiangani LN; Dilu AA; Moanda KA; Ilunga MJ; Makwanga ME; Stahnke T; Guthoff R
    Ophthalmic Epidemiol; 2020 Feb; 27(1):45-51. PubMed ID: 31790319
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroepidemiology of ocular toxoplasmosis-profile of an urban population.
    Jain SD; Uppal B; Mehta DK
    Indian J Pathol Microbiol; 1998 Oct; 41(4):387-90. PubMed ID: 9866896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis.
    London NJ; Hovakimyan A; Cubillan LD; Siverio CD; Cunningham ET
    Eur J Ophthalmol; 2011; 21(6):811-9. PubMed ID: 21374556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and serological profiles of ocular toxoplasmosis in the municipality of Natal, northeastern Brazil.
    Mendes NH; Oliveira CB; Garcia CA; Holanda CM; Andrade-Neto VF
    Trans R Soc Trop Med Hyg; 2014 Oct; 108(10):656-61. PubMed ID: 25096294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl-prolyl cis-trans isomerase A - A novel biomarker of multi-episodic (recurrent) ocular toxoplasmosis.
    Isenberg J; Golizeh M; Belfort RN; da Silva AJ; Burnier MN; Ndao M
    Exp Eye Res; 2018 Dec; 177():104-111. PubMed ID: 30063883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular toxoplasmosis in infants 0 to 12 months of age with congenital toxoplasmosis].
    González V L; Cardozo S O; Samudio A M; Mesquita R M
    Rev Chilena Infectol; 2022 Jun; 39(3):265-272. PubMed ID: 36156688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.